Available Day or Night Call us any time to schedule your free consultation
The goal of this trial was to see whether in patients with overweight and obesity, who dont have diabetes, if their risk of cardiovascular events could be reduced by treatment with semaglutide, explained Michael Lincoff, MD, cardiologist for Cleveland Clinic
Bismah Irfan, MD walks through the full procedure for both the prefilled pen and the compounded vial-and-syringe setup, the way she teaches it to her IVitality MD patients
Eventually, her provider suggested something new: semaglutide
Sadiya Khan wants to figure out why, what the harms may be of stopping therapy prematurely, and how to help patients continue their therapy
This proactive approach ensures that any potential side effects, including pancreatitis, are managed efficiently and that your treatment benefits aren't overshadowed by unforeseen risks